Sleep Disorders Trial, Recruiting NCT05414708 Sponsor: Walter Reed National Military Medical Center Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05414708
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are eligible in the Defense Enrollment Eligibility Reporting System (DEERS) (confirm with trial site)
  • People who are currently serving in the military (Active Duty) or veterans who left the military within the past 10 years
  • People with significant post-traumatic stress symptoms, based on a score of 31 or higher on a standard PTSD checklist called the PCL-5

Who may not be able to join:

  • People with a history of moderate, severe, or penetrating brain injury
  • People with a history of a psychotic disorder, bipolar disorder, or who are currently experiencing thoughts of harming themselves or others
  • People with a history of multiple sclerosis, Huntington's disease, or Alzheimer's disease
  • People with a history of stroke or heart attack
  • People with a history of a brain tumor
  • People with a history of seizures
  • People for whom MRI scans are not safe — for example, those who are pregnant, have metal implants or possible shrapnel in the body, have certain brain surgery clips, or have a pacemaker or similar implanted device
  • People who are not able to give informed consent to participate
  • People who have previously taken part in art therapy
  • People with a currently active substance use disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chandler Rhodes, PhD, WRNMMC

Phone: 301-400-3638

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Walter Reed National Military Medical Center
Registry
ClinicalTrials.gov
Start date
1 February 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The Primary Outcome Measure is analysis of functional neuroimaging metrics; The Primary Outcome Measure is analysis of functional neuroimaging metrics

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov